Abstract:Gene electrotransfer is an efficient and reproducible nonviral gene transfer technique useful for the nonpermanent expression of therapeutic transgenes. The present study established optimal conditions for the electrotransfer of reporter genes into mesenchymal stem cells (MSCs) isolated from rat bone marrow by their selective adherence to tissue-culture plasticware. The electrotransfer of the lacZ reporter gene was optimized by adjusting the pulse electric field intensity, electric pulse type, electropulsation… Show more
“…It was recently reported that electroporation of cells in a capillary system gave rise to an enhancement of transfection rate and cell viability when compared to the cuvette system (Kim et al 2008). In the conventional electroporation, using a cuvette, the reported cellular viabilities are generally below 70 % and most importantly the cell recoveries are rarely mentioned, with the exception of few studies with primary cells (Aluigi et al 2006;Ferreira et al 2008). In this work we achieved cell viabilities up to 90 % and cell recoveries near 50 %.…”
Section: Resultsmentioning
confidence: 52%
“…The number of pulses (1-3) did not greatly affect the number of GFP + cells contrarily to some reported studies, although using different cell lines and electroporation equipments (Lin et al 2009). It is well known that when cells are submitted to high electric pulses a major amount of DNA enter into the cells though concurrently an increase of cell death is observed (Ferreira et al 2008). Several studies, using different cells, have shown that a way to circumvent this fact is by decreasing electric pulse and increasing the duration of pulse (pulse width) or within low voltages use more than one pulse (Cemazar et al 2009).…”
Section: Resultsmentioning
confidence: 80%
“…In fact, previous reports have shown that the percentage of surviving cells increases with the decreasing medium conductivity (Ferreira et al 2008) suggesting that electroporation buffer is other parameter that might be considered on electrotransfer optimization protocols. Even though each electroporation equipment has a specific buffer suggested by the supplier, some authors have recently reported promising results of gene delivery efficiencies using accessible buffers of known composition (Ferreira et al 2008;Kang et al 2009). Actually, in one experiment transfection efficiency obtained with RB was slightly higher than those obtained with SB-PBS because 78 % of GFP + cells were obtained using 1 g of DNA.…”
Section: Resultsmentioning
confidence: 99%
“…In fact, high cell viabilities may be obtained even when few cells are recovered after being submitted to electric voltages. To our best knowledge few authors have published results regarding cell recovery and yield of transfection after electroporation of mammalian cells (Aluigi et al 2006;Ferreira et al 2008).…”
Microporation is an efficient method for delivering plasmid DNA molecules into cultured cells.Herein, we present the optimization of gene delivery by microporation using a Central Composite Design methodology. It was given relevance not only to the transfection efficiency but also to the cell recovery. Different amounts of DNA (1 and 3 g) mainly affected cell viabilities and cell recoveries, which decrease from 93 % to 76 % and from 47 % to 25 % respectively, when higher DNA quantity is used. With this work we suggest an easy methodology to improve transfection of mammalian cells underlining the feasibility to achieve 60% of gene delivery efficiencies whilst recovering 50 % of cells, with 90 % of viability.
“…It was recently reported that electroporation of cells in a capillary system gave rise to an enhancement of transfection rate and cell viability when compared to the cuvette system (Kim et al 2008). In the conventional electroporation, using a cuvette, the reported cellular viabilities are generally below 70 % and most importantly the cell recoveries are rarely mentioned, with the exception of few studies with primary cells (Aluigi et al 2006;Ferreira et al 2008). In this work we achieved cell viabilities up to 90 % and cell recoveries near 50 %.…”
Section: Resultsmentioning
confidence: 52%
“…The number of pulses (1-3) did not greatly affect the number of GFP + cells contrarily to some reported studies, although using different cell lines and electroporation equipments (Lin et al 2009). It is well known that when cells are submitted to high electric pulses a major amount of DNA enter into the cells though concurrently an increase of cell death is observed (Ferreira et al 2008). Several studies, using different cells, have shown that a way to circumvent this fact is by decreasing electric pulse and increasing the duration of pulse (pulse width) or within low voltages use more than one pulse (Cemazar et al 2009).…”
Section: Resultsmentioning
confidence: 80%
“…In fact, previous reports have shown that the percentage of surviving cells increases with the decreasing medium conductivity (Ferreira et al 2008) suggesting that electroporation buffer is other parameter that might be considered on electrotransfer optimization protocols. Even though each electroporation equipment has a specific buffer suggested by the supplier, some authors have recently reported promising results of gene delivery efficiencies using accessible buffers of known composition (Ferreira et al 2008;Kang et al 2009). Actually, in one experiment transfection efficiency obtained with RB was slightly higher than those obtained with SB-PBS because 78 % of GFP + cells were obtained using 1 g of DNA.…”
Section: Resultsmentioning
confidence: 99%
“…In fact, high cell viabilities may be obtained even when few cells are recovered after being submitted to electric voltages. To our best knowledge few authors have published results regarding cell recovery and yield of transfection after electroporation of mammalian cells (Aluigi et al 2006;Ferreira et al 2008).…”
Microporation is an efficient method for delivering plasmid DNA molecules into cultured cells.Herein, we present the optimization of gene delivery by microporation using a Central Composite Design methodology. It was given relevance not only to the transfection efficiency but also to the cell recovery. Different amounts of DNA (1 and 3 g) mainly affected cell viabilities and cell recoveries, which decrease from 93 % to 76 % and from 47 % to 25 % respectively, when higher DNA quantity is used. With this work we suggest an easy methodology to improve transfection of mammalian cells underlining the feasibility to achieve 60% of gene delivery efficiencies whilst recovering 50 % of cells, with 90 % of viability.
“…Nucleofection has been used successfully for transient transfection of human, bovine, rat and porcine MSCs, but has never been tested in BM-derived mMSCs. [34][35][36][37] Magnetically enhanced nucleic acid delivery (magnetofection) has not explored for any type of MSCs to date. We found that nucleofection is a very efficient transfection technique for mMSCs with transfection rates of B60%.…”
Section: Nonviral Gene Transfer Into Murine Mscsmentioning
Erythropoietin (EPO) acts on erythroblasts in the bone marrow (BM) to stimulate the formation of red blood cells. In this study, we wanted to determine whether BM-derived mesenchymal stromal cells (MSCs) can be used as cellular vehicles to deliver EPO in mice without the use of viral vectors. After isolation and characterization of murine MSCs (mMSCs), different transient transfection procedures were compared for their efficacy of gene transfer of the pEGFP-N2 plasmid. Nucleofection outperformed magnetofection and lipofection. Stably transfected mMSCs were generated by selection with G418-disulfate and single-cellcolony-forming unit (sc-CFU) assays without changes in their proliferation capacity and osteogenic/adipogenic differentiation potential. Next, murine EPO was stably introduced into mMSCs by nucleofection of a plasmid encoding the epo and egfp genes. Intraperitoneal transplantation of EPO-expressing mMSCs increased serum EPO levels, hematocrit and hemoglobin of C57BL/6 mice within 1 week. The hematocrit remained elevated for 5 weeks, but production of antibodies against both transgenes was detected in the hosts and serum EPO levels normalized. Our results suggest that nonviral gene delivery into MSCs can be used to enhance the known beneficial effects MSCs by additional production of therapeutic factors like EPO in vivo.
Osteoarthritis (OA) is a painful intractable disease that significantly affects patients' quality of life. However, current therapies, such as pain killers and joint replacement surgery, do not lead to cartilage protection. Mesenchymal stem cells (MSCs) have been proposed as an alternative strategy for OA therapy because MSCs can secrete chondroprotective and anti‐inflammatory factors. However, interleukin‐4 (IL‐4), a potent anti‐inflammatory cytokine, is barely produced by MSCs, and MSC therapy suffers from rapid MSC death following intra‐articular implantation. MSCs in spheroids survive better than naïve MSCs in vitro and in vivo. IL‐4‐transfected MSCs in spheroids (IL‐4 MSC spheroid) show increased chondroprotective and anti‐inflammatory effects in an OA chondrocyte model in vitro. Following intra‐articular implantation in OA rats, IL‐4 MSC spheroids show better cartilage protection and pain relief than naïve MSCs. Thus, IL‐4 MSC spheroid may potentiate the therapeutic efficacy of MSCs for OA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.